Youngevity International, Inc. Announces Closing of $5.58 Million Public Offering of Series D Cumulative Redeemable Perpetual Preferred Stock

YGYI today announced the closing of its previously announced underwritten public offering of 245,398 shares of its 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock at a price to the public of $22.75 per share. The Company received gross proceeds of approximately $5.58 million from the offering. The shares of Series D Preferred Stock trade on the Nasdaq Capital Market under the symbol “YGYIP.”  The shares of Series D Preferred Stock are not convertible into or exchangeable for any of the company’s other securities.

Youngevity International, Inc. Announces Timing of Regular Monthly Dividend for December 2019 for Series “D” Cumulative Redeemable Perpetual Preferred Stock

Youngevity International, Inc. (NASDAQ: YGYI), a leading multi-channel lifestyle company, today announced the timing for the payment of its declared regular monthly dividend of $0.203125 per share of its 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock (NASDAQ:YGYIP) for December 2019. The dividend will be payable on January 15, 2020 to holders of record as of December 31, 2019. The dividend will be paid in cash.

Youngevity International, Inc. Nasdaq YGYI, to Present at The Benchmark Company’s 8th Annual Discovery 1×1 Investor Conference

YGYI today announced that it will be presenting at The Benchmark Company’s 8th Annual Discovery 1×1 Investor Conference.  The conference is being held on December 4, 2019 at the New York Athletic Club in New York City.  Dave Briskie (President/CFO of Youngevity International) will be presenting YGYI to various institutional investors, family offices, and high net worth investors.

Youngevity International, Inc. Reports 2019 Third Quarter and Nine Months Results Q3 YTD Consolidated Revenues Up 14.0%

Youngevity International, Inc. (NASDAQ: YGYI), a leading multi-channel lifestyle company, today reported financial results for the three and nine months ended September 30, 2019. Steve Wallach, Chairman and CEO of Youngevity International stated, “Although we have recently made great strides in producing revenue growth this year, the third quarter posed a number of challenges as we faced seasonally slower sales for the direct selling segment and our commercial coffee segment contributed to a seasonally slower quarter. Additionally, our commercial hemp segment was still operating on a pre-revenue basis for this quarter. We enter Q4 with the anticipation of sales growth contribution coming from our latest acquisition within the direct selling segment and with Khrysos Industries beginning to generate revenue which has us anticipating finishing 2019 year with double digit revenue growth.”